XML 47 R27.htm IDEA: XBRL DOCUMENT
v3.22.4

Common and Preferred Shares | 12 Months Ended
--- | ---
Dec. 31, 2022
Equity [Abstract] |
Common and Preferred Shares | COMMON AND PREFERRED SHARES The following table shows authorized shares and provides a reconciliation of common shares issued and outstanding for the years ended December 31:
(Millions, except where indicated) |  | 2022 |  | 2021 |  | 2020
Common shares authorized (billions) (a) |  | 3.6 |  |  | 3.6 |  |  | 3.6 |
Shares issued and outstanding at beginning of year |  | 761 |  |  | 805 |  |  | 810 |
Repurchases of common shares |  | (20) |  |  | (46) |  |  | (7) |
Other, primarily stock option exercises and restricted stock awards granted |  | 2 |  |  | 2 |  |  | 2 |
Shares issued and outstanding as of December 31 |  | 743 |  |  | 761 |  |  | 805 |
(a)Of the common shares authorized but unissued as of December 31, 2022, approximately 18 million shares are reserved for issuance under employee stock and employee benefit plans. On September 23, 2019, the Board of Directors authorized the repurchase of up to 120 million common shares from time to time, subject to market conditions and in accordance with our capital plans. This authorization replaced the prior repurchase authorization and does not have an expiration date. During 2022, 2021 and 2020, we repurchased 20 million common shares with a cost basis of $3.3 billion, 46 million common shares with a cost basis of $7.6 billion, and 7 million common shares with a cost basis of $0.9 billion, respectively. The cost basis includes commissions paid of $4.2 million, $5.6 million and $1.0 million in 2022, 2021 and 2020, respectively. As of December 31, 2022, we had approximately 36 million common shares remaining under the Board share repurchase authorization. Common shares are generally retired by us upon repurchase (except for 2.4 million shares held as treasury shares as of December 31, 2022 and 2.5 million shares held as treasury shares as of both December 31, 2021 and 2020); retired common shares and treasury shares are excluded from the shares outstanding in the table above. The treasury shares, with a cost basis of $262 million, $271 million and $279 million as of December 31, 2022, 2021 and 2020, respectively, are included as a reduction to Additional paid-in capital in Shareholders’ equity on the Consolidated Balance Sheets. PREFERRED SHARES The Board of Directors may authorize the issuance of up to 20 million preferred shares at a par value of $1.66 2/3 per share without further shareholder approval. We have the following perpetual Fixed Rate Reset Noncumulative Preferred Share series issued and outstanding as of December 31, 2022:
|  | Series D |  |
Issuance date |  | August 3, 2021 |  |
Securities issued |  | 1,600 Preferred shares; represented by 1,600,000 depositary shares |  |
Dividend rate per annum |  | 3.55% through September 14, 2026; resets September 15, 2026 and every subsequent 5-year anniversary at 5-year Treasury rate plus 2.854% |  |
Dividend payment date |  | Quarterly beginning September 15, 2021 |  |
Earliest redemption date |  | September 15, 2026 |  |
Aggregate liquidation preference |  | $1,600 million |  |
Carrying value (a) |  | $1,584 million |  |
(a)Carrying value, presented in the Statements of Shareholders' Equity, represents the issuance proceeds, net of underwriting fees and offering costs. In the event of the voluntary or involuntary liquidation, dissolution or winding up of the Company, the preferred shares then outstanding take precedence over our common shares for the payment of dividends and the distribution of assets out of funds legally available for distribution to shareholders. We may redeem the outstanding series of preferred shares at $1 million per preferred share (equivalent to $1,000 per depositary share) plus any declared but unpaid dividends in whole or in part, from time to time, on any dividend payment date on or after the earliest redemption date, or in whole, but not in part, within 90 days of certain bank regulatory changes. In 2021, we paid $1.6 billion to redeem in full the previously outstanding Series B and Series C preferred shares. The difference between the redemption value and carrying value of the redeemed Series B and Series C preferred shares resulted in a $16 million reduction to net income available to common shareholders for the year ended December 31, 2021. There were no warrants issued and outstanding as of December 31, 2022, 2021 and 2020.

X
- Definition Disclosures related to the Company's activity related to its common and preferred shares and warrants, including information about share repurchase authorization, treasury shares, including cost basis, common shares authorized and a reconciliation of common shares issued and outstanding, common stock and preferred stock issuances for periods presented, and subsequent repurchases. + References No definition available. + Details
Name: | axp_CommonAndPreferredSharesAndWarrantsTextBlock
Namespace Prefix: | axp_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration